Critically, 91% of participants maintained their weight loss through week 48 without significant regain, which addresses one of the most common concerns about obesity pharmacotherapy: whether results hold over time
Bu platform, kullanclarn eitli rnler hakkndaki deneyimlerini paylamalarna olanak tanr ve bu sayede dier kullanclarn daha bilinli alveriler yapmalarn salar
Granata A, Maccarrone R, Anzaldi M, Leonardi G, Pesce F, Amico F, et al (2022) GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
Remove foods that worsen Ozempic side effects